| Title |
Lamotrigine for chronic neuropathic pain and fibromyalgia in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2013
|
| DOI | 10.1002/14651858.cd006044.pub4 |
| Pubmed ID | |
| Authors |
Philip J Wiffen, Sheena Derry, R Andrew Moore |
| Abstract |
This is an update of the original Cochrane review entitled Lamotrigine for acute and chronic pain published in Issue 2, 2007, and updated in Issue 2, 2011. Some antiepileptic medicines have a place in the treatment of neuropathic pain (pain due to nerve damage). This updated review adds no new additional studies looking at evidence for lamotrigine as an effective treatment for chronic neuropathic pain or fibromyalgia. The update uses higher standards of evidence than previously. |
X Demographics
The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 11 | 33% |
| United Kingdom | 4 | 12% |
| United States | 2 | 6% |
| Canada | 2 | 6% |
| India | 1 | 3% |
| Ireland | 1 | 3% |
| Benin | 1 | 3% |
| Germany | 1 | 3% |
| Unknown | 10 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 79% |
| Practitioners (doctors, other healthcare professionals) | 3 | 9% |
| Scientists | 3 | 9% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 299 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | <1% |
| United Kingdom | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 295 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 51 | 17% |
| Student > Ph. D. Student | 33 | 11% |
| Student > Bachelor | 33 | 11% |
| Researcher | 24 | 8% |
| Student > Doctoral Student | 21 | 7% |
| Other | 55 | 18% |
| Unknown | 82 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 104 | 35% |
| Nursing and Health Professions | 34 | 11% |
| Psychology | 14 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 5% |
| Neuroscience | 11 | 4% |
| Other | 28 | 9% |
| Unknown | 94 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2023.
All research outputs
#1,245,322
of 24,488,567 outputs
Outputs from Cochrane database of systematic reviews
#2,739
of 12,927 outputs
Outputs of similar age
#13,890
of 317,928 outputs
Outputs of similar age from Cochrane database of systematic reviews
#49
of 219 outputs
Altmetric has tracked 24,488,567 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,927 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,928 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.